LEI 5493000M08EL707Q0J03

Sanofi-Aventis Deutschland GmbH

Group parent: SANOFISAN · FP

Awards tracked

36

Value

€1.88M

Countries

DE

Download sample CSV

Contract awards & public grants

FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2026-06-02

—

EXIT-CVD → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2026-03-31

—

Germany – Pharmaceutical products – Vereinbarung nach § 130c Abs. 1 SGB V für das Arzneimittel Dupixent mit dem Wirkstoff Dupilumab → Sanofi-Aventis Deutschland GmbH

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · DE · Tender · 2026-02-26

—

Patient Relevant Osteoarthritis endpoints using Big data Evaluation → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2025-12-02

—

Breakthrough Regulatory Innovation and Development throuGh sandbox Environments → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2025-11-07

—

UNderstanding Lipid ImmunoMetabolIsm To trEat Disease → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2025-07-10

—

EMBL Interdisciplinary Postdocs - Life in Context → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2025-05-12

—

Development of Chitosan-based Immobilized Catalysts for H/D Exchange in Continuous Flow Systems → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2025-03-19

—

Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2024-12-12

—

Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2024-12-05

—

Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2024-11-12

—

Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2024-07-26

—

Macrocycles for Drug Discovery → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2024-07-10

€260,539

Photocatalytic Industrial Applications → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2024-05-30

€260,539

REAL-WORLD IMPLEMENTATION, DEPLOYMENT AND VALIDATION OF EARLY DETECTION TOOLS AND LIFESTYLE ENHANCEMENT → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2023-11-13

—

European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2023-10-27

—

Isotopic Labeling of Biotherapeutics → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2022-07-14

€521,078

Advancing Reaction Platforms for Drug Discovery → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2022-07-04

€260,539

Real World Handling of Protein Drugs - Exploration, Evaluation and Education → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2021-07-05

—

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2020-04-16

—

Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2019-12-17

—

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2019-08-22

—

Biomarkers in Atopic Dermatitis and Psoriasis → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2019-02-27

—

European Screening Centre; Unique Library for Attractive Biology → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2018-12-18

—

Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2018-06-21

—

Hypoglycaemia - REdefining SOLutions for better liVEs → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2018-04-30

—

Liver Investigation: Testing Marker Utility in Steatohepatitis → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2017-10-09

—

Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2017-09-12

—

Rheuma Tolerance for Cure → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2017-08-25

—

Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2017-03-10

—

Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2016-12-20

—

Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881 → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2016-06-07

—

Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH). → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2015-12-16

€81,000

Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2015-12-07

—

ISOTOPIC LABELING FOR DRUG INNOVATION → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2015-08-10

€249,216

Rapid Bioprocess Development → SANOFI-AVENTIS DEUTSCHLAND GMBH

European Commission · DE · Grant · 2014-12-18

€249,216

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.